UK Pharma Sector ‘Not Ready’ For No-Deal Brexit
Executive Summary
A leaked government note has thrown doubt on the ability of the pharma sector to be ready for a no-deal Brexit in October, even though some of the contenders to be the next prime minister say there is nothing to fear from the UK leaving the EU without a deal.
You may also be interested in...
No-Deal Brexit 'Very Bad' For Business And Patients
Peter Martin, COO of Norgine, is concerned about the ‘mood music’ in the political environment in the UK, and warns about the risks of the UK leaving the EU without a deal in place.
‘Impossible' To Prepare UK Supply Chain For October No-Deal Brexit
The UK parliament's Exiting the EU Committee has heard strong words from industry representatives who say that the sector will not be ready for a no-deal Brexit in in October and that such a scenario would result in stockpiling problems, drug shortages and safety issues.
Pharma Told To Maintain Drug Stockpiles Despite Six-Month Brexit Delay
An agreement to delay Brexit has brought no reprieve for the pharmaceutical sector, which must remain at a heightened state of preparedness as a no-deal scenario is still a possibility. Industry says it will seek clarity on the practical implications of this.